Posters
Vous trouverez ci-dessous en téléchargement la liste des posters classés par thèmes et qui seront présentés lors du Congrès.
Pour connaître les horaires de présentation de ces posters, référez-vous au programme.
(Format des posters : 1,50 m de haut par 0,90 m de large)
PW01 DMD - Clinical and genetic observations
PW02 DMD - Molecular and cell therapy
PW03 Treatment approaches to the mdx mouse model
PW04 DMD physiopathology
PW05 Myogenic cells and myostatin
PW06 SMA and ALS - Molecular pathogenesis and treatment
PW07 SMA and ALS - Clinical and genetic findings
PW08 LGMD (part 1) - Calpain and dysferlin
PW09 LGMD (part 2) : sarcoglycans, caveolin and other forms
PW10 FSHD and OPMD
PW11 DM1 and DM2 - clinical findings
PW12 DM1 - Pathogenesis and treatment
PW13 Nucleopathies and other dominant dystrophies
PW14 Congenital myopathies - RYR1, SEPN1 and myotubular
PW15 Congenital myopathies - Nemalin myopathies, tropomyosin mutations and others
PW16 Myofibrillar myopathies and distal myopathies
PW17 Congenital muscular dystrophies
PW18 Congenital myasthenias, Andersen syndrome and myasthenia
PW19 Mitochondrial disorders
PW20 Glycogenosis and other metabolic myopathies
PW21 Inflammatory myopathies
PW22 Cardiomyopathies and experimental models
PW23 Hereditary neuropathies
PW24 Pharmacological therapies - Target identifications / clinical trials
PW25 Pharmacological therapies - Evaluation and animal models
PW26 Gene therapy of muscular dystrophy
PW27 Cell therapies - Myoblasts
PW28 Cell therapies - Myogenic precursor cells
PW29 Cell therapies - Muscle embryogenesis
PW30 Myogenesis and cell transplantation
PW31 Satellite cells and muscle homeostasis
PW32 Functional assessment of muscle
PW33 Animal models (Part 1)
PW34 Animal models (Part 2)
PW35 Cardiac, smooth, and other muscles
PW36 Muscle assessment, scales and patients’ registries
PW37 Myotonias and miscellaneous
PW38 Young investigators symposium
PW39 Young investigators symposium - lectures
Pour connaître les horaires de présentation de ces posters, référez-vous au programme.
(Format des posters : 1,50 m de haut par 0,90 m de large)
PW01 DMD - Clinical and genetic observations
PW02 DMD - Molecular and cell therapy
PW03 Treatment approaches to the mdx mouse model
PW04 DMD physiopathology
PW05 Myogenic cells and myostatin
PW06 SMA and ALS - Molecular pathogenesis and treatment
PW07 SMA and ALS - Clinical and genetic findings
PW08 LGMD (part 1) - Calpain and dysferlin
PW09 LGMD (part 2) : sarcoglycans, caveolin and other forms
PW10 FSHD and OPMD
PW11 DM1 and DM2 - clinical findings
PW12 DM1 - Pathogenesis and treatment
PW13 Nucleopathies and other dominant dystrophies
PW14 Congenital myopathies - RYR1, SEPN1 and myotubular
PW15 Congenital myopathies - Nemalin myopathies, tropomyosin mutations and others
PW16 Myofibrillar myopathies and distal myopathies
PW17 Congenital muscular dystrophies
PW18 Congenital myasthenias, Andersen syndrome and myasthenia
PW19 Mitochondrial disorders
PW20 Glycogenosis and other metabolic myopathies
PW21 Inflammatory myopathies
PW22 Cardiomyopathies and experimental models
PW23 Hereditary neuropathies
PW24 Pharmacological therapies - Target identifications / clinical trials
PW25 Pharmacological therapies - Evaluation and animal models
PW26 Gene therapy of muscular dystrophy
PW27 Cell therapies - Myoblasts
PW28 Cell therapies - Myogenic precursor cells
PW29 Cell therapies - Muscle embryogenesis
PW30 Myogenesis and cell transplantation
PW31 Satellite cells and muscle homeostasis
PW32 Functional assessment of muscle
PW33 Animal models (Part 1)
PW34 Animal models (Part 2)
PW35 Cardiac, smooth, and other muscles
PW36 Muscle assessment, scales and patients’ registries
PW37 Myotonias and miscellaneous
PW38 Young investigators symposium
PW39 Young investigators symposium - lectures
